Who owns BioSante Pharmaceuticals?

Key details on BioSante Pharmaceuticals (Ticker: BPAX)

Who owns BioSante Pharmaceuticals?

Is BPAX a good stock to own? Find out who bought BioSante Pharmaceuticals, who sold BioSante Pharmaceuticals (BPAX) stock, and who holds a large position in BioSante Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Vanguard 3.32M $2.26M March 31, 2012
Tang Capital Management 2.83M $1.92M March 31, 2012
BAM Management 2.19M $5.00M Sept. 30, 2011
STATE STREET CORPORATION 1.80M $1.22M March 31, 2012
UBS AG 1.25M $846904 March 31, 2012
Jacobs Levy Equity Management 778141 $529135 March 31, 2012
Geode Capital Management 755106 $513472 March 31, 2012
Perceptive Advisors 650000 $325000 Dec. 31, 2011
TIAA-CREF Investment Management 464949 $316165 March 31, 2012
Perella Weinberg Partners Capital Management 390000 $265200 March 31, 2012
Barclays 348000 $236640 March 31, 2012
GOLDMAN SACHS 332238 $225921 March 31, 2012
AQR Capital Management 329900 $164950 Dec. 31, 2011
Bank of America Corporation 261100 $130550 Dec. 31, 2011
CalPERS 206219 $140228 March 31, 2012
Knight Capital 199402 $135593 March 31, 2012
Jefferies 192000 $130560 March 31, 2012
Charles Schwab Investment Management 146800 $111568 March 31, 2012
CITADEL ADVISORS 146080 $99334 March 31, 2012
ING Investment Management Co Address: 10 State House Square 143900 $97852 March 31, 2012
Nomura Holdings 111000 $75480 March 31, 2012
Asset Management Investors 107908 $73377 March 31, 2012
ALLIANCEBERNSTEIN 103400 $70312 March 31, 2012
Diamondback Capital Management 100000 $50000 Dec. 31, 2011
Teachers Advisors 97234 $66119 March 31, 2012
WMS Partners 89450 $245987 March 31, 2012
Manulife Asset Management 88978 $0 March 31, 2012

Who sold BioSante Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Kopp Investment Advisors Sept. 30, 2011 5.38M $12.27M
Jennison Associates Sept. 30, 2011 1.77M $4.03M
Manatuck Hill Partners Sept. 30, 2011 1.50M $3.42M
Balyasny Asset Management Sept. 30, 2011 1.48M $3.37M
Gardner Lewis Asset Management Sept. 30, 2011 878981 $2.00M
ESSEX INVESTMENT MANAGEMENT Sept. 30, 2011 723081 $0
Eudaimonia Asset Management Sept. 30, 2011 643191 $1.47M
Driehaus Capital Management Sept. 30, 2011 571367 $1.30M
Emerald Advisers Sept. 30, 2011 560025 $1.28M
Deerfield Management Company Sept. 30, 2011 550000 $1.25M
Partner Fund Management Sept. 30, 2011 507622 $1.16M
Soros Fund Management Sept. 30, 2011 450000 $1.03M
Allianz Global Investors of America Sept. 30, 2011 366700 $836076
Partner Investment Management Sept. 30, 2011 332331 $757714
Capstone Investment Advisors Sept. 30, 2011 301200 $686736
Bridgeway Capital Management Sept. 30, 2011 282300 $643644
NOBLE PARTNERS Sept. 30, 2011 130000 $296400
RHUMBLINE ADVISERS Sept. 30, 2011 117606 $268141
Condor Capital Management Sept. 30, 2011 109000 $248520
Emerald Mutual Fund Advisers, Trust Sept. 30, 2011 94046 $214424
Oppenheimer & Co Sept. 30, 2011 93192 $211545
Metropolitan Life Insurance Company Sept. 30, 2011 92307 $210459
Broadfin Capital June 30, 2011 752047 $2.07M
HIGHBRIDGE CAPITAL MANAGEMENT June 30, 2011 218806 $601716
Highland Capital Management June 30, 2011 193530 $532207
GRT Capital Partners June 30, 2011 192700 $529925
Guggenheim Capital, LLC Managers June 30, 2011 101268 $265322
Dr. Jeffrey R. Jay, M.D March 31, 2011 7.81M $15.46B
Hudson Bay Capital Management March 31, 2011 2.22M $4.39M
D. E. Shaw & Co Dec. 31, 2010 154796 $253865
CQS Cayman Limited Partnership June 30, 2010 100000 $176000